| Date | Title | Description |
| 22.07.2025 | Achieving 93.8% cell viability with UBCO’s latest bioprinted lung model | Want to speak at AMA: Energy 2025 or AMA: Automotive & Mobility 2025? Submit your application now!
Researchers at the University of British Columbia’s Okanagan (UBCO) campus have bioprinted a human airway model combining key lung cell t... |
| 21.07.2025 | What happens when you 3D print inside a living cell? Scientists found out | Want to speak at AMA: Energy 2025 or AMA: Automotive & Mobility 2025? Submit your application now!
Researchers from J. Stefan Institute and the University of Ljubljana in Slovenia have achieved a scientific first by 3D printing tiny fun... |
| 04.07.2025 | TissueTinker’s bioprinted tumors offer new cancer drug testing model | Secure your spot now for exclusive AM insights at our Additive Manufacturing Advantage online conference covering aerospace, space, and defense!
McGill University’s spinout TissueTinker is exploring a new bioprinting approach that could imp... |
| 30.09.2024 | National Politics | Kamala Harris turns Biden’s $493 billion climate legacy into a footnote | “It’s not clear how much appetite the public has for more climate policy this soon,” said Kevin Book, managing director of the Washington consultancy ClearView Energy Partners LLC. “On the airwaves and in the campaign messaging, energy has ... |
| 30.01.2024 | New Carcinotech funding to expand tumor 3D printing commercialization | Edinburgh-based tumor 3D printing specialists Carcinotech has successfully raised £4.2 million in an investment round led by Eos Advisory (Eos) and the Investment Fund for Scotland (IFS).
This is the first equity deal from the £150 million ... |
| 18.12.2023 | Aston University to unlock bioprinting avenues with Quantum X bio and BBSRC grant | After securing a £612,176 grant from the Biotechnology and Biological Sciences Research Council (BBSRC), Aston University is set to integrate a Quantum X bio 3D printer into its research facilities.
Developed in partnership with BICO compan... |
| 09.10.2023 | CELLINK and Carcinotech partner to transform cancer drug development with 3D bioprinting | Carcinotech and 3D bioprinting firm CELLINK have announced a partnership to accelerate cancer drug development with 3D bioprinted tumor models.
The partnership will focus on the development and commercialization of cutting-edge protocols fo... |
| 30.08.2023 | Researchers 4D print personalized “smart implants” to treat breast cancer | Nominations are now open for the 3D Printing Industry Awards 2023. Who are the leaders in 3D printing? Find out on November 30th when the winners across twenty categories will be announced during a London-based live awards ceremony.
Researc... |
| 30.01.2023 | Qualified3D and MetShape collaborate with young minds for a microgravity experiment | Michigan-based additive manufacturing services provider Qualified3D and German additive manufacturing service provider MetShape have assisted students from International Space Station (ISS) Lab at San Jose-based Valley Christian High School... |
| 13.01.2023 | 3D-печать органов: как биопринтер может спасти жизнь | Обычный принтер функционирует в двухмерном пространстве, перенося изображение на какой-нибудь материал. 3D-принтер во многом совершенствует данную технологию, поскольку ему доступны оси X, Y и Z. Трёхмерная печать сводится к послойному конс... |
| 31.03.2022 | CollPlant to trial 3D bioprinted breast implants in breakthrough animal study | Regenerative medicine specialist CollPlant (NASDAQ: CLGN) has revealed that the 3D bioprinted breast tissues it’s developing are set to enter animal trials in the very near future.
Alongside the release of its FY 2021 results, which show th... |
| 25.03.2022 | AddUp-built metal 3D printer to undergo microgravity testing on the ISS | French industrial 3D printer manufacturer AddUp has revealed that a new system it has been helping develop is set to be launched into orbit for testing onboard the International Space Station (ISS).
Working as part of the European Space Age... |
| 23.03.2022 | MatTek Enters Distribution Agreement and Strategic Partnership with Cell4Pharma | MatTek Enters Distribution Agreement and Strategic Partnership with Cell4Pharma
Wed, Mar 23, 2022 14:00 CET Report this content
MatTek Life Sciences will distribute Cell4Pharma’s ciPTEC renal cells and utilize the technology in the developm... |
| 18.03.2022 | Infertility research boost as scientists 3D bioprint human testicular cells for the first time | In what is thought to be a world-first, researchers from the University of British Columbia (UBC) have successfully 3D bioprinted human testicular cells.
Having found some early signs of sperm production potential, the team hopes to one day... |
| 01.03.2022 | CELLINK Launches the BIO CELLX, a First of its Kind Biodispensing Platform to Automate 3D Cell Culture | CELLINK Launches the BIO CELLX, a First of its Kind Biodispensing Platform to Automate 3D Cell Culture
Tue, Mar 01, 2022 08:00 CET Report this content
The BIO CELLX provides cell biologist with pre-validated protocols to eliminate barriers ... |
| 23.02.2022 | CollPlant partners with CELLINK in bid to address $2.8BN regenerative breast implant market | Regenerative medicine specialist CollPlant has partnered with BICO firm CELLINK in an effort to ramp up its production of 3D bioprinted breast implants.
Currently undergoing preclinical trials, CollPlant’s bioprinted grafts are designed to ... |
| 18.02.2022 | 3D bioprinting project to deliver BRIGHTER alternative to animal testing | A European Union (EU) funded project is seeking to reduce animal testing within experimental medical research by means of 3D bioprinting.
Coordinated by the Institute of Bioengineering of Catalonia (IBEC), the BRIGHTER (Bioprinting by light... |
| 09.02.2022 | Trestle Biotherapeutics licenses kidney implant 3D bioprinting technology from Harvard | 3D Printing Industry is currently seeking feedback on material usage across the sector. Have your say in the Spotlight on Resin 3D Printing Survey now.
San Diego-based bioengineering start-up Trestle Biotherapeutics has gained a license for... |
| 25.01.2022 | Engineers develop haptic feedback sleeve and 3D printed glasses that allow blind people to ‘see’ | Researchers at the Technical University of Munich (TUM) have developed a novel infrared (IR) goggle-based setup with the potential to enable the visually impaired to effortlessly navigate obstacles in their daily lives.
Composed of two IR c... |
| 17.01.2022 | Astronauts test 3D bioprinted skin bandages in space | Astronauts on the International Space Station (ISS) are testing 3D bioprinted bandages made of their own cells that could be used to better heal flesh wounds in space.
The German Space Agency (DLR) is leading the experiment which was launch... |
| 17.12.2021 | Inventia Life Science raises $25M, launches ‘RASTRUM’ 3D bioprinting technology in the U.S. | Australian 3D bioprinting specialist Inventia Life Science has announced the closure of a Series B funding round that has seen it raise $25 million (USD).
Led by Blackbird Ventures and supported by long-term backer Skip Capital, the investm... |
| 15.12.2021 | CELLINK and Nanoscribe join forces to launch the Quantum X bio, the world’s most accurate 3D bioprinter | CELLINK and Nanoscribe join forces to launch the Quantum X bio, the world’s most accurate 3D bioprinter Wed, Dec 15, 2021 09:00 CET
The Quantum X bio combines CELLINK’s bioprinting expertise with the engineering excellence of Nanoscribe to ... |
| 13.12.2021 | BICO and Nanochon announce $1.5 million partnership to develop regenerative joint implants | 3D bioprinting firm BICO has announced an initial $1.5 million contract manufacturing deal with regenerative joint replacement start-up Nanochon.
The deal will see Nanochon purchase products and services worth $1.5 million from BICO’s SCIEN... |
| 10.12.2021 | BICO’s CELLINK Bioprinters Used by CTIBIOTECH to Produce World’s First Immunized Human Skin Model | BICO’s CELLINK Bioprinters Used by CTIBIOTECH to Produce World’s First Immunized Human Skin Model Fri, Dec 10, 2021 09:00 CET
The breakthrough was achieved by CELLINK’s longtime customer CTIBIOTECH and the NOVOPLASM Research Consortium by l... |
| 30.11.2021 | CTIBIOTECH develops novel 3D bioprinting platform to treat colon cancer | Regenerative medicine firm CTIBIOTECH has developed a new 3D bioprinting platform to deliver personalized medicine for patients with colorectal cancer.
Developed in partnership with the Medical University of Plovdiv and the UMHAT-Eurohospit... |
| 26.11.2021 | “World’s first” 3D printed immunized skin model enables cold plasma wound healing treatment for burns | The NOVOPLASM consortium has announced it is the “first in the world” to develop cold plasma technology for the treatment of infected burns and the wound healing of skin grafts.
Regenerative medicine firm CTIBIOTECH, the French Armed Forces... |
| 24.11.2021 | CELLINK empowers the Swedish 3Rs Center´s network to create awareness on how to reduce animal testing | CELLINK empowers the Swedish 3Rs Center´s network to create awareness on how to reduce animal testing Wed, Nov 24, 2021 09:00 CET
CELLINK’s vision and dream is to be able to contribute to the future of medicine by addressing some of the key... |
| 28.10.2021 | 3D Systems to expand bioprinting program after buying Volumetric Biotechnologies for $400M | U.S. 3D printer manufacturer 3D Systems has unveiled plans to expand on its bioprinting program after acquiring Volumetric Biotechnologies for $400 million.
Bought for an initial $45 million, with a further $355 million set to be paid upon ... |
| 14.10.2021 | BICO strengthens IP Portfolio with Patents in the United States and Sweden for 3D bioprinting of Temperature Sensitive Bioinks | BICO strengthens IP Portfolio with Patents in the United States and Sweden for 3D bioprinting of Temperature Sensitive Bioinks Thu, Oct 14, 2021 15:00 CET
These innovations will allow for higher cell viability and better reproducibility whe... |
| 21.09.2021 | BICO Launches 3D Bioprinting contract research offering from CELLINK, MatTek and Visikol | BICO Launches 3D Bioprinting contract research offering from CELLINK, MatTek and Visikol Tue, Sep 21, 2021 14:00 CET
The three companies have joined forces to present customers a first of its kind full-service 3D biomanufacturing and in vit... |
| 13.08.2021 | Change of name and short name (ticker) for shares in CELLINK AB (publ) | Change of name and short name (ticker) for shares in CELLINK AB (publ) Fri, Aug 13, 2021 08:00 CET
The name for the share on Nasdaq Stockholm will be changed from CELLINK AB (publ) to BICO Group AB (publ).
The shares' short name (ticker) wi... |
| 12.08.2021 | The name change has been registered: CELLINK AB (publ) new name is BICO Group AB (publ) | The name change has been registered: CELLINK AB (publ) new name is BICO Group AB (publ) Thu, Aug 12, 2021 15:10 CET
As of today, the name change from CELLINK AB (publ) to BICO Group AB (publ) has been registered with the Swedish Companies R... |
| 12.08.2021 | Invitation to earnings call for interim report January-June 2021 | Invitation to earnings call for interim report January-June 2021 Thu, Aug 12, 2021 08:00 CET
On August 18, 08.00 (CEST), the interim report January-June 2021 will be published and in connection with this, an earnings call will be arranged a... |
| 06.08.2021 | Bulletin from Extraordinary General Meeting in CELLINK AB (publ) | Bulletin from Extraordinary General Meeting in CELLINK AB (publ) Fri, Aug 06, 2021 09:10 CET
At the extraordinary general meeting in CELLINK AB (publ), held on August 6, 2021, the following resolutions were passed.
The extraordinary general... |
| 30.07.2021 | CELLINK announces an increase in number of shares and votes | CELLINK announces an increase in number of shares and votes Fri, Jul 30, 2021 08:00 CET
The number of shares and votes in CELLINK AB (publ) (“CELLINK”) have increased as a result of an issue in kind of 262,320 shares of series B which was c... |
| 25.07.2021 | Cellink Acquires Discover Echo | Photo courtesy of Discover Echo. Discover Echo’s microscope, called the Revolve, combines two commonly used designs (the upright and inverted) Cellink, a multibillion-dollar unicorn startup in Sweden, has acquired San Diego-based Discover E... |
| 19.07.2021 | CELLINK launches the S.NEST, a high-throughput microbioreactor with real-time monitoring to ensure maximum cell growth and streamlined workflows | CELLINK launches the S.NEST, a high-throughput microbioreactor with real-time monitoring to ensure maximum cell growth and streamlined workflows Mon, Jul 19, 2021 08:00 CET
CYTENA Bioprocess Solutions, a CELLINK company, has launched the S.... |
| 07.07.2021 | Notice of Extraordinary General Meeting of CELLINK AB (publ) | Notice of Extraordinary General Meeting of CELLINK AB (publ) Wed, Jul 07, 2021 17:30 CET
The shareholders of CELLINK AB (publ), reg. no. 559050-5052 (the “Company” or “Cellink”), with registered office in Gothenburg, are hereby invited to t... |
| 07.07.2021 | CELLINK has initiated the process of changing name to BICO | CELLINK has initiated the process of changing name to BICO Wed, Jul 07, 2021 17:40 CET
Today, the plans for the name change from CELLINK to BICO have been announced in conjunction with the publication of the notice to the extraordinary gene... |
| 06.07.2021 | Visikol partners with MatTek to leverage their advanced cell culture models in its suite of drug discovery services | Visikol partners with MatTek to leverage their advanced cell culture models in its suite of drug discovery services Tue, Jul 06, 2021 15:00 CET
Over the last two months, both MatTek and Visikol have been acquired by CELLINK, the world’s lea... |
| 30.06.2021 | CELLINK completes the acquisition of Discover Echo | CELLINK completes the acquisition of Discover Echo Wed, Jun 30, 2021 18:15 CET
As announced on June 26, 2021, CELLINK AB (publ) (“CELLINK”) entered into an agreement to acquire Discover Echo Inc. (“Discover Echo”), an innovative and revolut... |
| 30.06.2021 | CELLINK announces an increase in number of shares and votes | CELLINK announces an increase in number of shares and votes Wed, Jun 30, 2021 08:00 CET
The number of shares and votes in CELLINK AB (publ) (“CELLINK”) have increased as a result of a directed new issue of 57,911 shares of series B which wa... |
| 30.06.2021 | CELLINK has been granted its first patent of robotic systems for personalized and automated aesthetic medical procedures | CELLINK has been granted its first patent of robotic systems for personalized and automated aesthetic medical procedures Wed, Jun 30, 2021 08:45 CET
CELLINK has been granted a patent for a unique set of robotic systems for transcutaneous de... |
| 29.06.2021 | CELLINK has been granted a patent for "Cellulose Nanofibrillar Bioink for 3D Bioprinting for Cell Culturing, Tissue Engineering and Regenerative Medicine Applications" from European Patent O... | CELLINK has been granted a patent for "Cellulose Nanofibrillar Bioink for 3D Bioprinting for Cell Culturing, Tissue Engineering and Regenerative Medicine Applications" from European Patent Office Tue, Jun 29, 2021 08:00 CET
CELLIN... |
| 26.06.2021 | CELLINK has entered into an agreement to acquire Discover Echo Inc., an innovative and revolutionary microscopy company | CELLINK has entered into an agreement to acquire Discover Echo Inc., an innovative and revolutionary microscopy company Sat, Jun 26, 2021 05:45 CET
CELLINK AB (publ) ("CELLINK") has entered into an agreement with the shareholders ... |
| 23.06.2021 | CELLINKs EpiDerm ™ skin model has been approved by the OECD as a stand-alone in-vitro test method for phototoxicity | CELLINKs EpiDerm ™ skin model has been approved by the OECD as a stand-alone in-vitro test method for phototoxicity Wed, Jun 23, 2021 15:00 CET
MatTek Life Sciences, a subsidiary of CELLINK, today announced the acceptance of the EpiDerm™ Ph... |
| 31.05.2021 | CELLINK completes the acquisition of Nanoscribe | CELLINK completes the acquisition of Nanoscribe Mon, May 31, 2021 18:15 CET
As announced on May 19, 2021, CELLINK AB (publ) (“CELLINK”) entered into an agreement to acquire the German company Nanoscribe Holding GmbH (“Nanoscribe”), an award... |
| 24.05.2021 | CELLINK Bioprinting moves to Entré Kallebäck | CELLINK Bioprinting moves to Entré Kallebäck Mon, May 24, 2021 08:00 CET
CELLINK’s successful and innovation driven Bioprinting business is in an exciting development phase and will from the beginning of 2022 relocate to the newly built Ent... |
| 20.05.2021 | CELLINK has acquired Visikol, a contract research services company focused on advanced imaging, 3D cell culture assays and digital pathology | CELLINK has acquired Visikol, a contract research services company focused on advanced imaging, 3D cell culture assays and digital pathology Thu, May 20, 2021 08:00 CET
CELLINK has acquired Visikol Corp., an American contract research servi... |
| 19.05.2021 | CELLINK has entered into an agreement to acquire Nanoscribe, a market leading 3D bioprinting company based on Two-Photon Polymerization technology | CELLINK has entered into an agreement to acquire Nanoscribe, a market leading 3D bioprinting company based on Two-Photon Polymerization technology Wed, May 19, 2021 19:25 CET
CELLINK AB (publ) ("CELLINK") has entered into an agree... |
| 12.05.2021 | Interim report January-March 2021: High organic growth, strengthened gross margin, and strategic acquisitions | First quarter, 2021 Net sales amounted to MSEK 129.5 (38.0), which corresponded to an increase of 241% (55) compared to the corresponding period previous year, of which 62% (25) was organic growth. Operating profit before depreciation (EBIT... |
| 12.05.2021 | CELLINK AB (PUBL)
Interim report January-March 2021: High organic growth, strengthened gross margin, and strategic acquisitions | First quarter, 2021 Net sales amounted to MSEK 129.5 (38.0), which corresponded to an increase of 241% (55) compared to the corresponding period previous year, of which 62% (25) was organic growth. Operating profit before depreciation (EBIT... |
| 31.03.2021 | CELLINK AB (PUBL)
Cellink : Invitation to CELLINKs digital Capital Markets Day on May 12, 2021 with focus on the bioconvergence agenda | CELLINK invites investors, analysts, shareholders, and media to a digital Capital Markets Day (CMD) on Wednesday May 12, 2021 at 2-5pm (CEST).
We are the frontrunners in the evolving life science universe where we together with our customer... |
| 31.03.2021 | CELLINK announces an increase in number of shares and votes | CELLINK announces an increase in number of shares and votes Wed, Mar 31, 2021 08:00 CET
The number of shares and votes in CELLINK AB (publ) have increased as a result of a new issue of 666,028 shares of series B which was carried out as par... |
| 15.02.2021 | Swedish biotech Startup Cellink acquires Finnish robotics firm Ginolis for €70 million in cash, stock | Sweden’s CELLINK is to acquire the Finland-based robotics and diagnostic automation company Ginolis for €70 million in a mix of cash and stock.
Founded in 2010 and headquartered in Oulu, Finland with a manufacturing site in Estonia as well ... |
| 22.10.2020 | CELLINK AB (PUBL)
Q4 19/20: Strong organic growth and important strategic acquisition under continued challenging conditions | CELLINK publishes the interim report for the period June 2020 - August 2020 as well as the report for the first 12 months. The report is available on the company's website: https://cellink.com/investors/ (https://cellink.com/investors/.%20)... |
| 09.07.2020 | CELLINK AB (PUBL)
Q3 19/20: Continued growth and Main market listing during an ongoing pandemic | CELLINK publishes the interim report for the period March 2020 - May 2020 as well as the report for the first nine months. The report is available on the company's website: https://cellink.com/investors/. This press release presents a summa... |
| 23.12.2019 | MIT Technology Review presents the Innovators Under 35 Europe 2019 | Since 1999, MIT Technology Review recognizes the young innovators and most talented entrepreneurs from different countries who are developing new technologies to help solve the problems that affect our society nowadays.
These young bright m... |
| 05.08.2019 | Cellink to Acquire cytena, for €30.25M | Cellink AB (Nasdaq First North: CLNK), a Swedish 3D bioprinter provider, is to acquire cytena GmbH, a German life science company focusing on single-cell technologies, for €30.25M.
The acquisition strengthens Cellink’s product offering and ... |
| 16.07.2018 | Gothenburg-based CELLINK secures a €2.5 million EU grant to print human cancer tumors | CELLINK, an innovative 3D Bioprinting startup from Sweden, today announced it receives a €2.5 million EU grant for the development and commercializing of its TumorPrint project.
The project aims to develop and commercialize a specific Biopr... |
| 25.06.2018 | Implantable 3D-printed organs could be coming sooner than you think | At MBC Biolabs, an incubator for biotech startups in San Francisco’s Dogpatch neighborhood, a team of scientists and interns working for the small startup Prellis Biologics have just taken a big step on the path toward developing viable 3D-... |
| 24.03.2017 | Swedish scientists successfully implant 3D-printed human cartilage cells in baby mice | In what could potentially serve as an important moment in the quest to 3D-print body parts, a team of scientists from Sweden’s Sahlgrenska Academy and Chalmers University of Technology have managed to successfully implant human cartilage ce... |
| - | Successful exit for High-Tech Gründerfonds (HTGF) – HTGF sells its Cytena shares to CELLINK in a trade sale | The shareholders of Cytena GmbH (“Cytena”) have agreed to sell all Cytena shares to CELLINK AB (“CELLINK”) for a purchase price of 30.25M euros (“acquisition”). Through CELLINK’s complimentary technology offering cytena sees great synergies... |
